• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Venture

Nation 1 launches new early-stage, EUR 35m-EUR 40m fund

Nation 1 launches new early-stage, EUR 35m-EUR 40m fund
Marek Moravec, managing partner at Nation 1
  • Katka Krosnar
  • 22 March 2023
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Czech sponsor Nation 1 has begun fundraising for its second early-stage VC fund with a EUR 35m-EUR 40m target, Managing Partner Marek Moravec told Unquote.

With a first close planned for 1Q24, the new vehicle is looking to attract private investors from Western Europe as well as institutional investors and at least one bank.

The fund already has around EUR 10m in hard commitments and additional soft commitments, Moravec said, adding that much of this comes from investors from its first vehicle. Launched in 2019, Fund I raised EUR 35m from investors such as the European Investment Fund (EIF) as well as family offices and high-net-worth individuals from the Czech Republic and Slovakia.

Investments
Nation 1 will continue to focus on healthtech as well as human and environmental health, Moravec said. These key segments will account for 70% of deployment, with the other 30% planned for other sectors.

In addition to Czech Republic-based businesses and Czech founders of companies established abroad, Nation 1 will scout for targets in the former Yugoslavia, Bulgaria and Romania, Moravec said. Around 80% of the fund will be invested in Czech founders and the remainder into founders from other CEE markets, he added.

Nation 1 seeks companies with global potential, Moravec said. It could also invest in some companies with Ukrainian founders who are migrating to central and eastern Europe, including the Czech Republic, he said.

Moravec says Nation 1's main difference from other Czech VC firm is its aim to be a day-one investor, coming "super early", Moravec said. It is also more opportunistic and open to investing into B2C companies rather than focusing just on the B2B software segment, he said, adding that it looks for solid teams, good products and scalability.

Nation 1 initially deploys tickets of up to EUR 200,000 at the pre-seed stage, doubling and tripling the investments on the best companies, with follow-ons involving co-investors, Moravec said.

Ticket sizes will average EUR 0.5m, with a total investment of EUR 2m over several rounds into any one company, Moravec said. A maximum 15% of the total fund size will be invested into any company, he said.

Fund I
Nation 1's first fund is more than 50% invested and is expected to make around eight final deals this year. It could make two or three exits next year, Moravec said.

The firm has 30 companies in its portfolio, including Czech menstrual pants producer Snuggs, online psychotherapist session platform Hedepy, VR headset manufacturer VRgineers, diabetes digital program startup Vitadio and Daytrip, which offers tourists door-to-door transport.

It proactively sources targets through research including screening market data and organising events, as well as through its network and sometimes from other funds.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Venture
  • CEE
  • Technology
  • Czech Republic

More on Venture

Redalpine expands leadership team amid CHF 1bn-plus fundraise
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities

Partner Gareth Jefferies discusses early-stage deployment plans and advantages of supporting startups throughout their lifecycle

  • Venture
  • 14 August 2023
Medicxi raises USD 400m to invest in single-focus life sciences companies
Medicxi raises USD 400m to invest in single-focus life sciences companies

GP's fourth fund will deploy USD 10m-USD 20m tickets in narrow indications of unmet need; backed by pharma

  • Venture
  • 27 July 2023
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline

UK-based impact investorт€™s female leaders discuss deployment plans and the advantages of its syndicate co-investment strategy

  • Venture
  • 21 July 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013